KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

BeOne Medicines (ONC) Return on Equity (2016 - 2025)

Historic Return on Equity for BeOne Medicines (ONC) over the last 10 years, with Q3 2025 value amounting to 0.02%.

  • BeOne Medicines' Return on Equity rose 2700.0% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year increase of 2700.0%. This contributed to the annual value of 0.19% for FY2024, which is 300.0% up from last year.
  • BeOne Medicines' Return on Equity amounted to 0.02% in Q3 2025, which was up 2700.0% from 0.05% recorded in Q2 2025.
  • In the past 5 years, BeOne Medicines' Return on Equity ranged from a high of 0.02% in Q3 2025 and a low of 0.45% during Q1 2023
  • Over the past 5 years, BeOne Medicines' median Return on Equity value was 0.3% (recorded in 2021), while the average stood at 0.28%.
  • As far as peak fluctuations go, BeOne Medicines' Return on Equity skyrocketed by 3000bps in 2021, and later crashed by -1400bps in 2022.
  • BeOne Medicines' Return on Equity (Quarter) stood at 0.3% in 2021, then plummeted by -46bps to 0.44% in 2022, then skyrocketed by 46bps to 0.24% in 2023, then grew by 21bps to 0.19% in 2024, then soared by 109bps to 0.02% in 2025.
  • Its last three reported values are 0.02% in Q3 2025, 0.05% for Q2 2025, and 0.11% during Q1 2025.